Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine
Numerous studies have demonstrated the antidepressant effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists in various rodent models. Importantly, it has been shown that the antidepressant effects of mGlu2/3 receptor antagonists in rodent models are similar to those of ketamine,...
Gespeichert in:
| Veröffentlicht in: | International journal of molecular sciences 2019-03, Vol.20 (6), p.1270 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 1270 |
| container_title | International journal of molecular sciences |
| container_volume | 20 |
| creator | Chaki, Shigeyuki Fukumoto, Kenichi |
| description | Numerous studies have demonstrated the antidepressant effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists in various rodent models. Importantly, it has been shown that the antidepressant effects of mGlu2/3 receptor antagonists in rodent models are similar to those of ketamine, which exerts rapid and long-lasting antidepressant effects in patients with major depressive disorders, including patients with treatment-resistant depression. In addition, the synaptic mechanisms underlying the effects of mGlu2/3 receptor antagonists are reported to be similar to those underlying the effects of ketamine. The roles of the serotonergic system in the antidepressant effects of mGlu2/3 receptor antagonists have recently been demonstrated. Moreover, it was investigated how mGlu2/3 receptor antagonists interact with the serotonergic system to exert antidepressant effects. Notably, the same neural mechanisms as those underlying the effects of ketamine may be involved in the antidepressant actions of the mGlu2/3 receptor antagonists. In this review, we shall summarize the antidepressant potential of mGlu2/3 receptor antagonists and their mechanisms of action in comparison with those of ketamine. In particular, we shall focus on the roles of the serotonergic system in the antidepressant actions of mGlu2/3 receptor antagonists. |
| doi_str_mv | 10.3390/ijms20061270 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6470808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2193169893</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-5ef8abfbfd5d25e755c7ed3b2eac9bcafdf84643517068f70d8d3ea9b157c5073</originalsourceid><addsrcrecordid>eNpdkc1rGzEQxUVpaL56yzkIeskhTvSxWu32EDAmdUsDBTs9C6125MjsSo6kDfi_7xq7we1pZpjfPN7wELqi5I7zmty7dZ8YISVlknxAZ7RgbDKO8uNRf4rOU1oTwjgT9Sd0ykklKSvKM_S6CB3gYPESYsjBQ1w5g5fblKHHzuP8Anjqs2thEyEl7TOemuyCT7ujft4N7J7jBRjY5BB3qF4F71JOX_HS9a7T0eUtzgH_hKx75-ESnVjdJfh8qBfo97fH59n3ydOv-Y_Z9GliCsryRICtdGMb24qWCZBCGAktbxhoUzdG29ZWRVlwQSUpKytJW7UcdN1QIY0gkl-gh73uZmh6aA34HHWnNtH1Om5V0E79u_HuRa3CmyoLSSpSjQI3B4EYXgdIWfUuGeg67SEMSTFac1rWVc1H9Mt_6DoM0Y_vKcb5CI5WyUjd7ikTQ0oR7LsZStQuS3Wc5YhfHz_wDv8Nj_8BCG6czw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2332198460</pqid></control><display><type>article</type><title>Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Chaki, Shigeyuki ; Fukumoto, Kenichi</creator><creatorcontrib>Chaki, Shigeyuki ; Fukumoto, Kenichi</creatorcontrib><description>Numerous studies have demonstrated the antidepressant effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists in various rodent models. Importantly, it has been shown that the antidepressant effects of mGlu2/3 receptor antagonists in rodent models are similar to those of ketamine, which exerts rapid and long-lasting antidepressant effects in patients with major depressive disorders, including patients with treatment-resistant depression. In addition, the synaptic mechanisms underlying the effects of mGlu2/3 receptor antagonists are reported to be similar to those underlying the effects of ketamine. The roles of the serotonergic system in the antidepressant effects of mGlu2/3 receptor antagonists have recently been demonstrated. Moreover, it was investigated how mGlu2/3 receptor antagonists interact with the serotonergic system to exert antidepressant effects. Notably, the same neural mechanisms as those underlying the effects of ketamine may be involved in the antidepressant actions of the mGlu2/3 receptor antagonists. In this review, we shall summarize the antidepressant potential of mGlu2/3 receptor antagonists and their mechanisms of action in comparison with those of ketamine. In particular, we shall focus on the roles of the serotonergic system in the antidepressant actions of mGlu2/3 receptor antagonists.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms20061270</identifier><identifier>PMID: 30871246</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adenylate cyclase ; Antidepressants ; Binding sites ; Brain ; Brain-derived neurotrophic factor ; Cerebral cortex ; Cognition ; Cognition & reasoning ; Drug abuse ; Glutamatergic transmission ; Glutamic acid receptors (metabotropic) ; Ketamine ; Kinases ; Mental depression ; Neurotoxicity ; Protein synthesis ; Proteins ; Review ; Roles ; Serotonin ; Side effects ; TrkB receptors ; Tropomyosin ; α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid ; α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors</subject><ispartof>International journal of molecular sciences, 2019-03, Vol.20 (6), p.1270</ispartof><rights>2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-5ef8abfbfd5d25e755c7ed3b2eac9bcafdf84643517068f70d8d3ea9b157c5073</citedby><cites>FETCH-LOGICAL-c412t-5ef8abfbfd5d25e755c7ed3b2eac9bcafdf84643517068f70d8d3ea9b157c5073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470808/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470808/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53768,53770</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30871246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chaki, Shigeyuki</creatorcontrib><creatorcontrib>Fukumoto, Kenichi</creatorcontrib><title>Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Numerous studies have demonstrated the antidepressant effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists in various rodent models. Importantly, it has been shown that the antidepressant effects of mGlu2/3 receptor antagonists in rodent models are similar to those of ketamine, which exerts rapid and long-lasting antidepressant effects in patients with major depressive disorders, including patients with treatment-resistant depression. In addition, the synaptic mechanisms underlying the effects of mGlu2/3 receptor antagonists are reported to be similar to those underlying the effects of ketamine. The roles of the serotonergic system in the antidepressant effects of mGlu2/3 receptor antagonists have recently been demonstrated. Moreover, it was investigated how mGlu2/3 receptor antagonists interact with the serotonergic system to exert antidepressant effects. Notably, the same neural mechanisms as those underlying the effects of ketamine may be involved in the antidepressant actions of the mGlu2/3 receptor antagonists. In this review, we shall summarize the antidepressant potential of mGlu2/3 receptor antagonists and their mechanisms of action in comparison with those of ketamine. In particular, we shall focus on the roles of the serotonergic system in the antidepressant actions of mGlu2/3 receptor antagonists.</description><subject>Adenylate cyclase</subject><subject>Antidepressants</subject><subject>Binding sites</subject><subject>Brain</subject><subject>Brain-derived neurotrophic factor</subject><subject>Cerebral cortex</subject><subject>Cognition</subject><subject>Cognition & reasoning</subject><subject>Drug abuse</subject><subject>Glutamatergic transmission</subject><subject>Glutamic acid receptors (metabotropic)</subject><subject>Ketamine</subject><subject>Kinases</subject><subject>Mental depression</subject><subject>Neurotoxicity</subject><subject>Protein synthesis</subject><subject>Proteins</subject><subject>Review</subject><subject>Roles</subject><subject>Serotonin</subject><subject>Side effects</subject><subject>TrkB receptors</subject><subject>Tropomyosin</subject><subject>α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid</subject><subject>α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkc1rGzEQxUVpaL56yzkIeskhTvSxWu32EDAmdUsDBTs9C6125MjsSo6kDfi_7xq7we1pZpjfPN7wELqi5I7zmty7dZ8YISVlknxAZ7RgbDKO8uNRf4rOU1oTwjgT9Sd0ykklKSvKM_S6CB3gYPESYsjBQ1w5g5fblKHHzuP8Anjqs2thEyEl7TOemuyCT7ujft4N7J7jBRjY5BB3qF4F71JOX_HS9a7T0eUtzgH_hKx75-ESnVjdJfh8qBfo97fH59n3ydOv-Y_Z9GliCsryRICtdGMb24qWCZBCGAktbxhoUzdG29ZWRVlwQSUpKytJW7UcdN1QIY0gkl-gh73uZmh6aA34HHWnNtH1Om5V0E79u_HuRa3CmyoLSSpSjQI3B4EYXgdIWfUuGeg67SEMSTFac1rWVc1H9Mt_6DoM0Y_vKcb5CI5WyUjd7ikTQ0oR7LsZStQuS3Wc5YhfHz_wDv8Nj_8BCG6czw</recordid><startdate>20190313</startdate><enddate>20190313</enddate><creator>Chaki, Shigeyuki</creator><creator>Fukumoto, Kenichi</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190313</creationdate><title>Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine</title><author>Chaki, Shigeyuki ; Fukumoto, Kenichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-5ef8abfbfd5d25e755c7ed3b2eac9bcafdf84643517068f70d8d3ea9b157c5073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenylate cyclase</topic><topic>Antidepressants</topic><topic>Binding sites</topic><topic>Brain</topic><topic>Brain-derived neurotrophic factor</topic><topic>Cerebral cortex</topic><topic>Cognition</topic><topic>Cognition & reasoning</topic><topic>Drug abuse</topic><topic>Glutamatergic transmission</topic><topic>Glutamic acid receptors (metabotropic)</topic><topic>Ketamine</topic><topic>Kinases</topic><topic>Mental depression</topic><topic>Neurotoxicity</topic><topic>Protein synthesis</topic><topic>Proteins</topic><topic>Review</topic><topic>Roles</topic><topic>Serotonin</topic><topic>Side effects</topic><topic>TrkB receptors</topic><topic>Tropomyosin</topic><topic>α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid</topic><topic>α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chaki, Shigeyuki</creatorcontrib><creatorcontrib>Fukumoto, Kenichi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chaki, Shigeyuki</au><au>Fukumoto, Kenichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2019-03-13</date><risdate>2019</risdate><volume>20</volume><issue>6</issue><spage>1270</spage><pages>1270-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Numerous studies have demonstrated the antidepressant effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists in various rodent models. Importantly, it has been shown that the antidepressant effects of mGlu2/3 receptor antagonists in rodent models are similar to those of ketamine, which exerts rapid and long-lasting antidepressant effects in patients with major depressive disorders, including patients with treatment-resistant depression. In addition, the synaptic mechanisms underlying the effects of mGlu2/3 receptor antagonists are reported to be similar to those underlying the effects of ketamine. The roles of the serotonergic system in the antidepressant effects of mGlu2/3 receptor antagonists have recently been demonstrated. Moreover, it was investigated how mGlu2/3 receptor antagonists interact with the serotonergic system to exert antidepressant effects. Notably, the same neural mechanisms as those underlying the effects of ketamine may be involved in the antidepressant actions of the mGlu2/3 receptor antagonists. In this review, we shall summarize the antidepressant potential of mGlu2/3 receptor antagonists and their mechanisms of action in comparison with those of ketamine. In particular, we shall focus on the roles of the serotonergic system in the antidepressant actions of mGlu2/3 receptor antagonists.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>30871246</pmid><doi>10.3390/ijms20061270</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1422-0067 |
| ispartof | International journal of molecular sciences, 2019-03, Vol.20 (6), p.1270 |
| issn | 1422-0067 1661-6596 1422-0067 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6470808 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Adenylate cyclase Antidepressants Binding sites Brain Brain-derived neurotrophic factor Cerebral cortex Cognition Cognition & reasoning Drug abuse Glutamatergic transmission Glutamic acid receptors (metabotropic) Ketamine Kinases Mental depression Neurotoxicity Protein synthesis Proteins Review Roles Serotonin Side effects TrkB receptors Tropomyosin α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors |
| title | Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T09%3A52%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Serotonergic%20System%20in%20the%20Antidepressant%20Actions%20of%20mGlu2/3%20Receptor%20Antagonists:%20Similarity%20to%20Ketamine&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Chaki,%20Shigeyuki&rft.date=2019-03-13&rft.volume=20&rft.issue=6&rft.spage=1270&rft.pages=1270-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms20061270&rft_dat=%3Cproquest_pubme%3E2193169893%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2332198460&rft_id=info:pmid/30871246&rfr_iscdi=true |